Hybrid drugs—a strategy for overcoming anticancer drug resistance?

M Szumilak, A Wiktorowska-Owczarek, A Stanczak - Molecules, 2021 - mdpi.com
Despite enormous progress in the treatment of many malignancies, the development of
cancer resistance is still an important reason for cancer chemotherapy failure. Increasing …

Promise and challenges in drug discovery and development of hybrid anticancer drugs

LK Gediya, VCO Njar - Expert opinion on drug discovery, 2009 - Taylor & Francis
Background: Because cancer is a complex disease, it is unlikely that a single mono
functional 'targeted'drug will be effective for treating this most advanced disease. Combined …

Highlights in resistance mechanism pathways for combination therapy

JMA Delou, ASO Souza, LCM Souza, HL Borges - Cells, 2019 - mdpi.com
Combination chemotherapy has been a mainstay in cancer treatment for the last 60 years.
Although the mechanisms of action and signaling pathways affected by most treatments with …

Combinatorial drug therapy in cancer-New insights

K Bhatia, A Das - Life Sciences, 2020 - Elsevier
Cancer can arise due to mutations in numerous pathways present in our body and thus has
many alternatives for getting aggravated. Due to this attribute, it gets difficult to treat cancer …

Recent advances (2015–2016) in anticancer hybrids

N Kerru, P Singh, N Koorbanally, R Raj… - European journal of …, 2017 - Elsevier
In spite of the development of a large number of novel anticancer drugs over the years,
Cancer remains as a prominent cause of death, worldwide. Numerous drugs that are …

Hybrid compounds as multitarget directed anticancer agents

E Kucuksayan, T Ozben - Current topics in medicinal chemistry, 2017 - ingentaconnect.com
Cancer is a multifactorial disease including interactions of complex genetic and
environmental factors. Clinical efficacy of anticancer chemotherapies is hampered by …

Concept of hybrid drugs and recent advancements in anticancer hybrids

AK Singh, A Kumar, H Singh, P Sonawane, H Paliwal… - Pharmaceuticals, 2022 - mdpi.com
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of
conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in …

Have molecular hybrids delivered effective anti-cancer treatments and what should future drug discovery focus on?

Shalini, V Kumar - Expert Opinion on Drug Discovery, 2021 - Taylor & Francis
Introduction Cancer continues to be a big threat and its treatment is a huge challenge
among the medical fraternity. Conventional anti-cancer agents are losing their efficiency …

Rational combinations of targeted cancer therapies: background, advances and challenges

H Jin, L Wang, R Bernards - Nature Reviews Drug Discovery, 2023 - nature.com
Over the past two decades, elucidation of the genetic defects that underlie cancer has
resulted in a plethora of novel targeted cancer drugs. Although these agents can initially be …

Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy

J Ye, J Wu, B Liu - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2023 - Elsevier
Despite some advances in targeted therapeutics of human cancers, curative cancer
treatment still remains a tremendous challenge due to the occurrence of drug resistance. A …